Fig. 5From: In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancerCell viability study of PAMAM G4.5-piperazinyl-FITC on 4T1 cells. This study was carried out by MTT assay at different concentrations at 24 h of incubation as described in “Methods” section. Viability percentages and their error bars are expressed as mean ± SD and represent the result of three experiments. No cytotoxicity from FITC-conjugated PAMAM G4.5 dendrimers was observed on this cell lineBack to article page